TISSUEBLUE
Generic: BRILLIANT BLUE G
Basic Information
Manufacturer
D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAOCULAR
FDA Set ID
9d4b28b4-c582-4e2c-abd9-f7e203378e2d
Indications & Usage
Indications & Usage TissueBlue 0.025% is indicated to selectively stain the internal limiting membrane (ILM).
TissueBlue 0.025% is a disclosing agent indicated to selectively stain the internal limiting membrane (ILM).
TissueBlue 0.025% is a disclosing agent indicated to selectively stain the internal limiting membrane (ILM).
Adverse Reactions
Adverse Reactions Adverse reactions that have been reported in procedures that included the use of Brilliant Blue G Ophthalmic Solution have often been associated with the surgical procedure.
These complications include retinal (retinal break, tear, hemorrhage, and detachment) and cataracts.
Adverse reactions that have been reported in procedures that included the use of TissueBlue 0.025% have often been associated with the surgical procedure.
The complications include retinal (retinal break, tear, hemorrhage, and detachment and cataracts.
To report SUSPECTED ADVERSE REACTIONS, contact Dutch Ophthalmic, USA at 1-800-75-DUTCH or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
These complications include retinal (retinal break, tear, hemorrhage, and detachment) and cataracts.
Adverse reactions that have been reported in procedures that included the use of TissueBlue 0.025% have often been associated with the surgical procedure.
The complications include retinal (retinal break, tear, hemorrhage, and detachment and cataracts.
To report SUSPECTED ADVERSE REACTIONS, contact Dutch Ophthalmic, USA at 1-800-75-DUTCH or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch